000 | 01962 a2200553 4500 | ||
---|---|---|---|
005 | 20250514183525.0 | ||
264 | 0 | _c20040519 | |
008 | 200405s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm0310840 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGuillon, Jean | |
245 | 0 | 0 |
_aSynthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cApr 2004 |
||
300 |
_a1997-2009 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntimalarials _xchemical synthesis |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 |
_aErythrocytes _xparasitology |
650 | 0 | 4 |
_aHemeproteins _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aPyrazines _xchemical synthesis |
650 | 0 | 4 |
_aPyridines _xchemical synthesis |
650 | 0 | 4 |
_aPyrroles _xchemical synthesis |
650 | 0 | 4 |
_aQuinoxalines _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aGrellier, Philippe | |
700 | 1 | _aLabaied, Mehdi | |
700 | 1 | _aSonnet, Pascal | |
700 | 1 | _aLéger, Jean-Michel | |
700 | 1 | _aDéprez-Poulain, Rébecca | |
700 | 1 | _aForfar-Bares, Isabelle | |
700 | 1 | _aDallemagne, Patrick | |
700 | 1 | _aLemaître, Nicolas | |
700 | 1 | _aPéhourcq, Fabienne | |
700 | 1 | _aRochette, Jacques | |
700 | 1 | _aSergheraert, Christian | |
700 | 1 | _aJarry, Christian | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 47 _gno. 8 _gp. 1997-2009 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm0310840 _zAvailable from publisher's website |
999 |
_c14772344 _d14772344 |